Document Detail


Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
MedLine Citation:
PMID:  8341116     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A total of 49 patients with paucibacillary leprosy (PB) who completed multidrug therapy (MDT) between 1985 and 1990 were analysed retrospectively for efficacy and complications; 20 (40.8%) patients had borderline-tuberculoid (BT), 13 (26.5%) had tuberculoid (TT), 1 (2.1%) had indeterminate (I) and 15 (30.0%) had pure neural (N) leprosy; 26 patients (76.5% of 34 non-neural leprosy) were skin biopsied for histological cure before MDT was stopped. Of these 26 patients, 19 had histological clearance at 6 months while the remaining 7 cleared beyond 1 year (18-36 months). The remaining 8 non-neural patients who refused rebiopsy had MDT for 6-8 months and the MDT was stopped when there was clinical clearance. Of the 15 neural (N) leprosy patients, 11 were given MDT for 6 months while the rest had 12-18 months of treatment; 1 patient with neural leprosy, who was treated for 6 months, relapsed with BT leprosy 18 months post-treatment. There were few complications among the 49 patients-4 (8.2%) patients developed reaction to dapsone, 1 (2.0%) had the dapsone syndrome, 2 (4.1%) had haemolytic anaemia and 1 (2.0%) had dapsone hepatitis; 7 (14.3%) patients had type I reaction.
Authors:
J T Lim; T Tan
Related Documents :
8222626 - Allergic contact dermatitis from para-tertiary-butylphenol-formaldehyde resin (ptbp-f-r...
18346026 - International open trial of uniform multi-drug therapy regimen for 6 months for all typ...
7500816 - Lagophthalmos in a multibacillary population under multidrug therapy in the people's re...
20236436 - Recognition and treatment of anaphylaxis.
11240576 - Operating conditions of psychiatric hospitals and early readmission--effects of high pa...
12806336 - Outcome of orthodontic space closure with a missing maxillary central incisor.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Leprosy review     Volume:  64     ISSN:  0305-7518     ISO Abbreviation:  Lepr Rev     Publication Date:  1993 Jun 
Date Detail:
Created Date:  1993-09-01     Completed Date:  1993-09-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0243711     Medline TA:  Lepr Rev     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  136-42     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Clofazimine / administration & dosage,  adverse effects
Dapsone / administration & dosage,  adverse effects
Drug Therapy, Combination
Female
Humans
Leprostatic Agents / administration & dosage*,  adverse effects
Leprosy / drug therapy*
Male
Middle Aged
Rifampin / administration & dosage,  adverse effects
Chemical
Reg. No./Substance:
0/Leprostatic Agents; 13292-46-1/Rifampin; 2030-63-9/Clofazimine; 80-08-0/Dapsone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Survey for secondary dapsone and rifampicin resistance in Cuba.
Next Document:  An epidemiological survey of deformities and disabilities among 14,257 cases of leprosy in 11 counti...